Risk factors for hypospadias in the estrogen receptor 2 gene

被引:41
作者
Beleza-Meireles, Ana
Kockum, Ingrid
Lundberg, Fredrik
Soderhall, Cilla
Nordenskjold, Agneta
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med, SE-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden
[3] Karolinska Univ Hosp, Astrid Lindgren Children Hosp, Dept Women & Child Hlth, Stockholm 17176, Sweden
关键词
D O I
10.1210/jc.2007-0543
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Hypospadias is a common inborn error of the male genitalia of complex, and still elusive, etiology. The presence of active estrogen receptors (ESRs) in the developing male urethra, predominantly the ESR2, has suggested a role of estrogens in the otherwise androgendependent male genital differetiation. Moreover, imbalances between these two steroid hormones have been suggested to disturb the external genital development. This has been supported by the association between longer (CA)n variants in the ESR2 gene with lower androgen levels as well as with hypospadias. Objective: The aim of this study was to analyze the effect of ESR2 gene variants on the risk to hypospadias. Design, Participants, and Methods: Four haplotype-tagging single nucleotide polymorphisms (rs2987983, rs1887994, rs1256040, and rs1256062), the (CA)n polymorphism, and two additional promoter single nucleotide polymorphisms (rs10483774 and rs1271572), mapping to a transcription factor binding region, were typed and analyzed in a Swedish cohort of 354 boys with nonsyndromic hypospadias and 380 healthy controls. Results: Association was identified with longer variants of the ( CA) n polymorphism in intron 6 and with a region of intense transcription factor binding, in the putative promoter region, mapping to rs2987983 and rs10483774. The two regions are in low-linkage disequilibrium, meaning that they are not necessarily inherited together as a haplotype; logistic regression analysis indicates that these two risk effects are not independent. Conclusions: The present study evidences two nonindependent risk factors for hypospadias in the ESR2 gene. We discuss possible mechanisms that explain how these variants may affect male urethral development.
引用
收藏
页码:3712 / 3718
页数:7
相关论文
共 41 条
[1]   MUTATIONS OF THE ANDROGEN RECEPTOR CODING SEQUENCE ARE INFREQUENT IN PATIENTS WITH ISOLATED HYPOSPADIAS [J].
ALLERA, A ;
HERBST, MA ;
GRIFFIN, JE ;
WILSON, JD ;
SCHWEIKERT, HU ;
MCPHAUL, MJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (09) :2697-2699
[2]   The RsaI polymorphism in the estrogen receptor-β gene is associated with male infertility [J].
Aschim, EL ;
Giwercman, A ;
Ståhl, O ;
Eberhard, J ;
Cwikiel, M ;
Nordenskjöld, A ;
Haugen, TB ;
Grotmol, T ;
Giwercman, YL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (09) :5343-5348
[3]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[4]   Urethral seam formation and hypospadias [J].
Baskin, LS ;
Erol, A ;
Jegatheesan, P ;
Li, YW ;
Liu, WH ;
Cunha, GR .
CELL AND TISSUE RESEARCH, 2001, 305 (03) :379-387
[5]   Hypospadias and endocrine disruption: Is there a connection? [J].
Baskin, LS ;
Himes, K ;
Colborn, T .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 (11) :1175-1183
[6]   Testicular dysgenesis syndrome: possible role of endocrine disrupters [J].
Bay, K ;
Asklund, C ;
Skakkebaek, NE ;
Andersson, AM .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 20 (01) :77-90
[7]   Polymorphisms of estrogen receptor β gene are associated with hypospadias [J].
Beleza-Meireles, A ;
Omrani, D ;
Kockum, I ;
Frisén, L ;
Lagerstedt, K ;
Nordenskjöld, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2006, 29 (01) :5-10
[8]   Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe [J].
Capurso, C ;
Solfrizzi, V ;
D'Introno, A ;
Colacicco, AM ;
Capurso, SA ;
Capurso, A ;
Panza, F .
EXPERIMENTAL GERONTOLOGY, 2004, 39 (10) :1567-1573
[9]   ORAL-CONTRACEPTIVE PILLS, GONADOTROPIN-RELEASING-HORMONE AGONISTS, OR USE IN COMBINATION FOR TREATMENT OF HIRSUTISM - A CLINICAL RESEARCH-CENTER STUDY [J].
CARR, BR ;
BRESLAU, NA ;
GIVENS, C ;
BYRD, W ;
BARNETTHAMM, C ;
MARSHBURN, PB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1169-1178
[10]   Effect of postmenopausal estrogen replacement on circulating androgens [J].
Casson, PR ;
ElkindHirsch, KE ;
Buster, JE ;
Hornsby, PJ ;
Carson, SA ;
Snabes, MC .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (06) :995-998